Guided Therapeutics Books Investment, Signs MOU with Potential China Distributor
April 15, 2015 at 01:33 AM EDT
Guided Therapeutics of the US booked $720,000 from a group of unidentified investors and signed an MOU to negotiate China distribution rights for a cervical cancer screening device, the LuViva ® Advanced Cervical Scan. The investment bought 4 million shares Guided Therapeutics stock and warrants for an additional 2 million shares. The shares are worth $560,000 at the current price. More details.... Stock Symbols: (OTCBB: GTHP) (OTCQB: GTHP) Share this with colleagues: // //